A comprehensive diagnosis and treatment system for borderline resectable pancreatic cancer based on portal vein reconstruction
10.3760/cma.j.cn113884-20220302-00080
- VernacularTitle:以门静脉系统重建为标准的交界可切除胰腺癌综合诊疗体系的探讨
- Author:
Qiang HE
1
;
Zhangyong REN
Author Information
1. 首都医科大学附属北京朝阳医院肝胆外科，北京 100020
- Keywords:
Pancreatic neoplasms;
Pancreatectomy;
Neoplasms staging;
Neoadjuvant the-rapy;
Allogeneic vascular replacement
- From:
Chinese Journal of Hepatobiliary Surgery
2022;28(8):561-566
- CountryChina
- Language:Chinese
-
Abstract:
Borderline resectable pancreatic cancer is a special subtype between resectable and unresectable pancreatic cancer. Although the tumor is technically suitable for resection, there is increased risk of positive margin after surgery. At present, there is no optimal diagnostical criteria and treatment options for borderline resectable pancreatic cancer. With the popularization of the concept of multidisciplinary diagnosis and treatment, neoadjuvant therapy has been widely used in borderline resectable pancreatic cancer, and received good outcomes in some centers. However, for patients with borderline resectable pancreatic cancer who are not sensitive to radiotherapy and chemotherapy, long time of neoadjuvant therapy may delay the best time for surgery. This article summarized the definition, classification criteria and the latest diagnosis and treatment progress of borderline resectable pancreatic cancer, and discussed the comprehensive treatment mode suitable for this kind of patients combined with the clinical experience of our center.
